| Robert Houser Jr, MD | |
|
353 Fairmont Blvd., Rapid City, SD 57701 | |
| (605) 719-1000 | |
| Not Available |
| Full Name | Robert Houser Jr |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 30 Years |
| Location | 353 Fairmont Blvd., Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578518726 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 4256 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Rapid City Hospital, Inc. | 6002729506 | 424 |
News Archive
Bioengineering, extracting health products from waste tobacco, stem cells, unemployment, wind energy; this week on MoneyTV, hosted by anchor Donald Baillargeon.
A new study from Pakistan suggests 'smart sample pooling' using population grouping with algorithms as a solution to the unavailability of test kits for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a virus that causes COVID-19 disease. The paper is published on the preprint server medRxiv on April 28, 2020.
An analysis of three previous studies of children and young adults with attention-deficit hyperactivity disorder quantifies for the first time the extent to which stimulant treatment reduces the development of mood disorders, school problems, conduct disorders, substance use disorders and other problems.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million.
› Verified 1 days ago
| Entity Name | Monument Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588185268 PECOS PAC ID: 5991616427 Enrollment ID: O20031111000854 |
News Archive
Bioengineering, extracting health products from waste tobacco, stem cells, unemployment, wind energy; this week on MoneyTV, hosted by anchor Donald Baillargeon.
A new study from Pakistan suggests 'smart sample pooling' using population grouping with algorithms as a solution to the unavailability of test kits for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a virus that causes COVID-19 disease. The paper is published on the preprint server medRxiv on April 28, 2020.
An analysis of three previous studies of children and young adults with attention-deficit hyperactivity disorder quantifies for the first time the extent to which stimulant treatment reduces the development of mood disorders, school problems, conduct disorders, substance use disorders and other problems.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million.
› Verified 1 days ago
| Entity Name | Monument Health Rapid City Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275553463 PECOS PAC ID: 6002729506 Enrollment ID: O20070625000144 |
News Archive
Bioengineering, extracting health products from waste tobacco, stem cells, unemployment, wind energy; this week on MoneyTV, hosted by anchor Donald Baillargeon.
A new study from Pakistan suggests 'smart sample pooling' using population grouping with algorithms as a solution to the unavailability of test kits for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a virus that causes COVID-19 disease. The paper is published on the preprint server medRxiv on April 28, 2020.
An analysis of three previous studies of children and young adults with attention-deficit hyperactivity disorder quantifies for the first time the extent to which stimulant treatment reduces the development of mood disorders, school problems, conduct disorders, substance use disorders and other problems.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Houser Jr, MD 353 Fairmont Blvd, Atten Medical Staff Services, Rapid City, SD 57701-6000 Ph: () - | Robert Houser Jr, MD 353 Fairmont Blvd., Rapid City, SD 57701 Ph: (605) 719-1000 |
News Archive
Bioengineering, extracting health products from waste tobacco, stem cells, unemployment, wind energy; this week on MoneyTV, hosted by anchor Donald Baillargeon.
A new study from Pakistan suggests 'smart sample pooling' using population grouping with algorithms as a solution to the unavailability of test kits for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a virus that causes COVID-19 disease. The paper is published on the preprint server medRxiv on April 28, 2020.
An analysis of three previous studies of children and young adults with attention-deficit hyperactivity disorder quantifies for the first time the extent to which stimulant treatment reduces the development of mood disorders, school problems, conduct disorders, substance use disorders and other problems.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million.
› Verified 1 days ago
Dr. Raymond W Nowaczyk, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-1000 | |
Mona Ahmed Elsayed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-1000 | |
Dr. Ramtin Thomas Ramsey, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-755-1000 | |
Naji Alhasnawi, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4520 Wentworth Dr, Rapid City, SD 57702 Phone: 410-302-8586 | |
Marina K Petukoff, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd., Rapid City, SD 57701 Phone: 605-719-1000 | |
John E. Looby, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd., Rapid City, SD 57701 Phone: 605-719-1000 | |
Chad B Hanna, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd., Rapid City, SD 57701 Phone: 605-719-1000 |